Nathalie Compagnone
Vorstandsvorsitzender bei Innovative Concepts in Drug Development SAS
Ursprung des Netzwerks ersten Grades von Nathalie Compagnone
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Innovative Concepts in Drug Development SAS
Innovative Concepts in Drug Development SAS BiotechnologyHealth Technology Innovative Concepts in Drug Development SAS develops and provides innovative proprietary screening platforms to the pharmaceutical development sector. The company was founded by Natahlie Compagnone in 2007 and is headquartered in Gemenos, France.
8
| Holding Company | Biotechnology | 8 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Nathalie Compagnone
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
Aventis, Inc. | Corporate Officer/Principal | ||
Rhone Poulanc Rorer, Inc. | Corporate Officer/Principal | ||
Melies SAS
Melies SAS Investment ManagersFinance Melies SAS (Melies) is an independent venture capital firm headquartered in Montpellier, France. It was founded in 2006 by Nicolas Dulion. | Investment Managers | President | |
Agence Française de Sécurité Sanitaire des Produits de Santé | Corporate Officer/Principal |
Statistik
International
Frankreich | 4 |
Vereinigte Staaten | 2 |
Deutschland | 2 |
Sektoral
Health Technology | 2 |
Finance | 2 |
Operativ
Corporate Officer/Principal | 9 |
Director/Board Member | 4 |
Founder | 3 |
President | 1 |
General Counsel | 1 |
Am stärksten vernetzte Beziehungen
- Börse
- Insiders
- Nathalie Compagnone
- Unternehmensverbindungen